(Q2)Dec 31, 2021 | (Q1)Sep 30, 2021 | (FY)Jun 30, 2021 | (Q2)Dec 31, 2020 | (Q1)Sep 30, 2020 | (FY)Jun 30, 2020 | |
---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||
Cash flow from continuing operating activities | -112.78%-3.51M | -125.46%-1.96M | 139.01%8.99M | 27.49M | 7.7M | -23.05M |
Net income from continuing operations | -7.81%8.55M | -48.16%2.78M | 204.00%10.09M | --9.28M | --5.36M | ---9.7M |
Operating gains losses | 7.63%-2.55M | -61.18%-1.4M | -204.48%-13.74M | ---2.77M | ---868K | --13.15M |
Depreciation and amortization | 114.95%5.64M | 49.08%4.03M | -3.13%11.44M | --2.62M | --2.71M | --11.81M |
Asset impairment expenditure | ---- | ---- | 242.15%4.38M | ---- | ---- | --1.28M |
Remuneration paid in stock | 500.00%90K | -200.00%-15K | -20.00%48K | --15K | --15K | --60K |
Remuneration paid in stock | --0 | --0 | 1,053.63%3.33M | --128K | --330K | --289K |
Deferred tax | ---- | ---- | 108.77%851K | ---- | ---- | ---9.71M |
Other non cashItems | 99.96%-2K | 218.18%13K | -472.58%-5.45M | ---4.7M | ---11K | ---952K |
Change In working capital | -146.93%-9.21M | -4,488.69%-7.37M | 93.31%-1.96M | --19.61M | --168K | ---29.27M |
-Change in receivables | -259.42%-13.96M | 36.15%-1.99M | -223.67%-2.52M | --8.76M | ---3.11M | --2.04M |
-Change in inventory | 5,609.02%7.33M | 0.91%-4.67M | 107.12%2.31M | ---133K | ---4.71M | ---32.45M |
-Change in prepaid assets | -177.81%-8.41M | 126.41%884K | -453.52%-4.12M | ---3.03M | ---3.35M | --1.16M |
-Change in payables and accrued expense | -44.44%8.45M | -116.42%-1.72M | 454.32%3.08M | --15.2M | --10.45M | --556K |
-Change in other current assets | -86.21%-2.61M | -94.97%116K | 220.42%1.5M | ---1.4M | --2.31M | ---1.24M |
-Change in other current liabilities | --0 | --0 | -431.09%-2.22M | --214K | ---1.41M | --669K |
Cash from discontinued investing activities | ||||||
Operating cash flow | -112.78%-3.51M | -125.46%-1.96M | 139.01%8.99M | --27.49M | --7.7M | ---23.05M |
Investing cash flow | ||||||
Cash flow from continuing investing activities | -436.13%-65.34M | -13.40%-7.85M | -4,777.11%-60.29M | -12.19M | -6.92M | 1.29M |
Net PPE purchase and sale | 72.92%-3.49M | -13.40%-7.79M | -106.08%-38.03M | ---12.87M | ---6.87M | ---18.46M |
Net business purchase and sale | ---- | ---- | -55.73%-23.56M | ---- | ---- | ---15.13M |
Net other investing changes | -113.16%-90K | -12.77%-53K | -96.25%1.31M | --684K | ---47K | --34.88M |
Cash from discontinued investing activities | ||||||
Investing cash flow | -436.13%-65.34M | -13.40%-7.85M | -4,777.11%-60.29M | ---12.19M | ---6.92M | --1.29M |
Financing cash flow | ||||||
Cash flow from continuing financing activities | 264.11%27.53M | 472.26%9.2M | 735.62%173.23M | -16.77M | 1.61M | 20.73M |
Net issuance payments of debt | 290.63%24.06M | 443.34%8.89M | -290.75%-37.5M | ---12.62M | --1.64M | --19.66M |
Net common stock issuance | ---- | ---- | ---32M | ---- | ---- | --0 |
Proceeds from stock option exercised by employees | ---- | ---- | ---7.94M | ---- | ---- | --0 |
Net other financing activities | 183.54%3.47M | 1,217.86%313K | 23,327.10%250.67M | ---4.16M | ---28K | --1.07M |
Cash from discontinued financing activities | ||||||
Financing cash flow | 264.11%27.53M | 472.26%9.2M | 735.62%173.23M | ---16.77M | --1.61M | --20.73M |
Net cash flow | ||||||
Beginning cash position | 2,871.39%123.08M | 6,963.34%123.68M | -36.92%1.75M | --4.14M | --1.75M | --2.78M |
Current changes in cash | -2,705.84%-41.33M | -125.26%-604K | 11,995.41%121.93M | ---1.47M | --2.39M | ---1.03M |
End cash Position | 2,962.76%81.75M | 2,871.39%123.08M | 6,963.34%123.68M | --2.67M | --4.14M | --1.75M |
Free cash from | -147.88%-7M | -1,275.06%-9.75M | 30.02%-29.04M | --14.62M | --830K | ---41.5M |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | Unqualified Opinion | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data